Who needs nine ACE inhibitors?
Author information unavailable
Abstract
Author information unavailable
Abstract
Nine angiotensin-converting enzyme (ACE) inhibitors are now marketed in the UK. The first, captopril, was introduced in 1981.1 Then followed enalapril,2 lisinopril,3 quinapril, perindopril and ramipril4 and, most recently, cilazapril, fosinopril and ▼trandolapril. Their place in the treatment of patients with heart failure5,6 and hypertension7 is now established, and a new indication as part of the treatment of myocardial infarction is increasingly being recognised. In this article we review the ACE inhibitors and ask if all nine are really needed.
OpenAlex reports 10 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Nine angiotensin-converting enzyme (ACE) inhibitors are now marketed in the UK. The first, captopril, was introduced in 1981.1 Then followed enalapril,2 lisinopril,3 quinapril, perindopril and ramipril4 and, most recently, cilazapril, fosinopril and ▼trandolapril. Their place in the treatment of patients with heart failure5,6 and hypertension7 is now established, and a new indication as part of the treatment of myocardial infarction is increasingly being recognised. In this article we review the ACE inhibitors and ask if all nine are really needed.
Key concepts: Quinapril, Perindopril, Fosinopril, Enalapril, Trandolapril, Captopril, Lisinopril, ACE inhibitor